You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypereosinophilic Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hypereosinophilic Syndrome Trial in Argentina, Spain, United States (Mepolizumab)

Recruiting
  • Hypereosinophilic Syndrome
  • Rochester, Minnesota
  • +8 more
Aug 11, 2022

BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

Recruiting
  • BCR-JAK2 Fusion Protein Expression
  • +11 more
  • Palo Alto, California
  • +3 more
Oct 5, 2022

Hypereosinophilic Syndrome Trial (Depemokimab, Placebo)

Recruiting
  • Hypereosinophilic Syndrome
  • Atlanta, Georgia
  • +18 more
Feb 1, 2023

Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)

Completed
Has Results
  • Eosinophilia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting
Has Results
  • Respiratory System Agents
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022

Familial Hypereosinophilia: Natural History and Markers of

Recruiting
  • Eosinophilia
  • Hypereosinophilic Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Hypereosinophilic Syndrome (HES) Trial (Nilotinib)

    No longer available
    • Hypereosinophilic Syndrome (HES)
    • (no location specified)
    Sep 14, 2021

    Hypereosinophilic Syndrome Trial in Worldwide (Benralizumab, Placebo)

    Recruiting
    • Hypereosinophilic Syndrome
    • Benralizumab
    • Placebo
    • La Jolla, California
    • +45 more
    Feb 2, 2023

    Eosinophilia, Hypereosinophilic Syndrome Trial in Stanford (Gleevec)

    Terminated
    • Eosinophilia
    • Hypereosinophilic Syndrome
    • Stanford, California
      Stanford University School of Medicine
    May 5, 2021

    Hypereosinophilic Syndrome Trial (Mepolizumab)

    No longer available
    • Hypereosinophilic Syndrome
    • (no location specified)
    Nov 23, 2020

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Hypereosinophilia and Hypereosinophilic Syndromes

    Recruiting
    • Eosinophilia
    • Hypereosinophilic Syndrome
    • Biological sample
    • Lille, France
      Hôpital Roger Salengro, CHU
    Aug 25, 2020

    Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis, Churg-Strauss Syndrome Trial in Cincinnati (Mepolizumab)

    Completed
    • Hypereosinophilic Syndromes
    • +3 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jul 27, 2020

    Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad Trial in Innsbruck (no intervention)

    Recruiting
    • Eosinophilic Asthma
    • +4 more
    • no intervention
    • Innsbruck, Austria
      University Clinic for Internal Medicine II
    Sep 2, 2020

    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

    Terminated
    • Adult Acute Basophilic Leukemia
    • +16 more
    • eltrombopag olamine
    • standard follow-up care
    • Atlanta, Georgia
    • +1 more
    Jul 20, 2022

    Hypercholesterolemia, Hyperbilirubinemia, Hyper IgE Syndrome Trial in Moscow, Orenburg (plasma exchange with albumin, plasma

    Recruiting
    • Hypercholesterolemia
    • +11 more
    • plasma exchange with albumin
    • plasma exchange without albumin
    • Moscow, Russian Federation
    • +1 more
    May 18, 2021

    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
    • +18 more
    • eltrombopag olamine
    • Cleveland, Ohio
      Case Comprehensive Cancer Center
    Nov 29, 2021

    Hypereosinophilic Syndrome Trial in Worldwide (Mepolizumab)

    Completed
    Has Results
    • Hypereosinophilic Syndrome
    • La Jolla, California
    • +35 more
    Jun 4, 2020

    Hypereosinophilia, Hypereosinophilic Syndrome Trial in Worldwide (mepolizumab)

    Completed
    • Hypereosinophilia
    • Hypereosinophilic Syndrome
    • San Diego, California
    • +28 more
    May 1, 2020

    Hypereosinophilic Syndrome Trial in Worldwide (Mepolizumab 300 mg, Placebo matching mepolizumab, Active OCS capsules (5 mg

    Completed
    Has Results
    • Hypereosinophilic Syndrome
    • Mepolizumab 300 mg
    • +3 more
    • San Diego, California
    • +42 more
    Feb 7, 2020

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Hypereosinophilic Syndrome Trial in Limoges (Scheduled exams and diagnosis)

    Unknown status
    • Hypereosinophilic Syndrome
    • Scheduled exams and diagnosis
    • Limoges, France
      Médecine Interne A
    Jun 4, 2019